Trial Details
COMPLETEDBasic Information
| Clinical ID | c1760 |
|---|---|
| Identifier | NCT00409682 |
| Trial Title | Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Adalimumab|BIOLOGICAL: Adalimumab|BIOLOGICAL: Adalimumab |
Participant Information
| Sponsor | Abbott |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-07 |
|---|---|
| Primary Completion Date | 2025-05-10 |
| Completion Date | 2025-05-10 |